The Generation of MHC Class I-Associated Peptides is only Partially Inhibited by Proteasome Inhibitors: Involvement of Nonproteasomal Cytosolic Proteases in Antigen Processing?

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 554-564

  Vinitsky, Alexander ^a   Antón, Luis C ^b   Snyder, Heidi Link ^b   Orlowski, Marian ^a   Bennink, Jack R ^b,c   Yewdell, Jonathan W ^b,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; ENZYME INHIBITOR; HLA ANTIGEN CLASS 1; LIGAND; MULTIENZYME COMPLEX; PEPTIDE; PROTEASOME; VIRUS ANTIGEN;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; CELL LINE; DRUG EFFECT; IMMUNOLOGY; MOUSE; ORTHOMYXOVIRUS; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIGANDS; MICE; MULTIENZYME COMPLEXES; ORTHOMYXOVIRIDAE; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; T-LYMPHOCYTES;

EID: 0031570893     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. York, I., and K. L. Rock. 1996. Presentation of antigens MHC class I molecules. Annu. Rev. Immunol. 14:369.
2. Heemels, M.-T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class-I restricted peptides. Annu. Rev. Biochem. 64:463.
3. Snyder, H. L., J. W. Yewdell, and J. R. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389.
4. Elliot, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481.
5. Glynne, R., S. H. Powis, S. Beck, A. Kelly, L.-A. Kerr, and J. Trowsdale. 1991. A proteosome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357.
6. Brown, M. G., J. Driscoll, and J. J. Monaco. 1991. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353:355.
7. Martinez, C. K., and J. J. Monaco. 1991. Homology of proteasome subunits to a major histocompatibilily complex-linked LMP gene. Nature 353:664.
8. Ortiz-Navarrete, V., A. Seelig, M. Gernold, S. Frentzel, P. M. Kloetzel, and G. J. Hammerling. 1991. Subunit of the "20S" proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353:662.
9. Gaczynska, M., K. L. Rock, and A. L. Goldberg. 1993. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264.
10. Driscoll, J., M. G. Brown, D. Finley, and J. J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262.
11. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1:533.
12. Fehling, H. J., W. Swat, C. Laplace, R. Kühn, K. Rajewsky, U. Müller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234.
13. Boes, B., H. Hengel, T. Ruppert, G. Multhaup, U. H. Koszinowski, and P. M. Kloetzel. 1994. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasome. J. Exp. Med. 179:901.
14. Ustrell, V., G. Pratt, and M. Rechsteiner. 1995. Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proc. Natl. Acad. Sci. USA 92:584.
15. Groettrup, M., T. Ruppert, L. Kuehn, L. Seeger, S. Standera, U. Koszinowski, and P. M. Kloetzel. 1995. The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem. 270:23808.
16. Yewdell, J. W., C. K. Lapham, I. Bacik, T. Spies, and J. R. Bennink. 1994. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient MHC class I restricted-presentation of viral antigens. J. Immunol. 152:1163.
17. d in proteasome subunit LMP2- and LMP7-deficient cells. Eur. J. Immunol. 24:1863.
18. Arnold, D., J. Driscoll, M. Adrolewicz, E. Hughes, P. Cresswell, and T. Spies. 1992. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 360:171.
19. Momburg, F., V. Ortiz-Navarrete, J. Neefjes, E. Goulmy, Y. van de Wal, H. Spits, S. J. Powis, G. W. Butcher, J. Howard, P. Walden, and G. Hämmerling. 1992. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 360:174.
20. Eytan, E., D. Ganoth, T. Armon, and A. Hershko. 1989. ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. Proc. Natl. Acad. Sci. USA 86:7751.
21. Michalek, M. T., E. P. Grant, C. Gramm, A. L. Goldberg, and K. L. Rock. 1993. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363:552.
22. 1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 154:511.
23. Grant, E. P., M. T. Michalek, A. L. Goldberg, and K. L. Rock. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J. Immunol. 155:3750.
24. Goth, S., V. Nguyen, and N. Shastri. 1996. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors. J. Immunol. 157:1894.
25. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
26. Harding, C. V., J. France, R. Song, J. M. Farah, S. Chatterjee, M. Iqbal, and R. Siman. 1995. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen pathway. J. Immunol. 155:1767.
27. Sijts, A. J. A. M., M. S. Villanueva, and E. G. Pamer. 1996. CTL epitope generation is tightly linked to cellular proteolysis of a Listeria monocytogenes antigen. J. Immunol. 156:1497.
28. Yang, B., Y. S. Hahn, C. S. Hahn, and T. J. Braciale. 1996. The requirement for proteasome activity in class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen. J. Exp. Med. 183:1545.
29. Dick, L. R., C. Aldrich, S. C. Jameson, C. R. Moomaw, B. C. Pramanik, C. K. Doyle, G. N. DeMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884.
30. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschützky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
31. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P. M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
32. Dick, T. P., T. Ruppert, M. Groettrup, P. M. Kloetzel, L. Kuehn, U. H. Koszinowski, S. Stevanovic, H. Schild, and H.-G. Rammensee. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253.
33. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H.-G. Rammensee, U. H. Koszinowski, and P. M. Kloetzel. 1996. A role for the proteasome regulator PA28α in antigen presentation. Nature 381:166.
34. Orlowski, M., C. Cardozo, and C. Michaud. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32:1563.
35. Wilk, S., and M. Orlowski. 1983. Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex. J. Neurochem. 40:842.
36. Almenoff, J., and M. Orlowski. 1983. Membrane-bound kidney metalloendopeptidase: interaction with synthetic substrates, natural peptides, and inhibitors. Biochemistry 22:590.
37. Vinitsky, A., C. Michaud, J. C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31:9421.
38. Yewdell, J. W., J. R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637.
39. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
40. Loken, M. R., and A. M. Stall. 1982. Flow cytometry as an analytical and preparative tool in immunology. J. Immunol. Methods 50:R85.
41. Tada, N., S. Kimura, A. Halzfied, and U. Hämmerling. 1980. Ly-m3: the H-3 region of mouse chromosome 2 controls a new surface alloantigen. Immunogenetics 11:441.
42. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773.
43. Fenteany, G., R. F. Standaert, G. A. Reichard, E. J. Corey, and S. L. Schreiber. 1994. A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. USA 91:3358.
44. Figueiredo-Pereira, M. E., K. A. Berg, and S. Wilk. 1994. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J. Neurochem. 63:1578.
45. Townsend, A., C. Öhlen, J. Bastin, H.-G. Ljunggren, L. Foster, and K. Kärre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
46. Salter, R. D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5:943.
47. DeMars, R., R. Rudersdorf, C. Chang, J. Petersen, J. Strandtmann, N. Korn, B. Sidwell, and H. T. Orr. 1985. Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc. Natl. Acad. Sci. USA 82:8183.
48. 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell 611:65.
49. Day, P. M., H. Esquivel, J. Lukszo, J. R. Bennink, and J. W. Yewdell. 1995. Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity 2:137.
50. Townsend, A., T. Elliot, V. Cerundolo, L. Foster, B. Barber, and A. Tse. 1990. Assembly of MHC class I molecules analyzed in vitro. Cell 62:285.
51. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
52. Nuchtern, J. G., J. S. Bonifacino, W. E. Biddison, and R. D. Klausner. 1989. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 339:223.
53. Kelly, A., S. H. Powis, R. Glynne, E. Radley, S. Beck, and J. Trowsdale. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353: 667.
54. Ortiz-Navarrete, V., and G. J. Hämmerling. 1991. Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc. Natl. Acad. Sci. USA 88:3594.
55. Ozato, K., N. Mayer, and D. H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533.
56. Catipovic, B., J. Dal Porto, M. Mage, T. E. Johansen, and J. P. Schneck. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611.
57. Bluestone, J. A., S. Jameson, S. Miller, and R. I. Dick. 1992. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757.
58. k-restricted cytotoxic T cell epitope in the NS1 protein of influenza virus using an MHC allele-specific motif. Virology 193:289.
59. k-restricted T cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J. Virol. 65:5401.
60. Heinemeyer, W., A. Gruhler, V. Mohrle, Y. Mahe, and D. H. Wolf. 1993. PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chymotryptic activity and degradation of ubiquitinated proteins. J. Biol. Chem. 268:5115.
61. Vinitsky, A., C. Cardozo, L. Sepp-Lorenzino, C. Michaud, and M. Orlowski. 1994. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes. J. Biol. Chem. 269: 29860.
62. Cardozo, C., A. M. Eleuteri, and M. Orlowski. 1995. Differences in catalytic activities and subunit pattern of multicatalytic proteinase complexes (proteasomes) isolated from bovine pituitary, lung, and liver. Changes in LMP7 and the component necessary for expression of the chymotrypsin-like activity. J. Biol. Chem. 270:22645.
63. Hughes, E. A., B. Ortmann, M. Surman, and P. Cresswell. 1996. The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J. Exp. Med. 183:1569.
64. Suh, W.-K., E. K. Mitchell, Y. Yang, A. Peterson, G. L. Waneck, and D. B. Williams. 1996. MHC Class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184:337.
65. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
66. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
67. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Apella, D. F. Hunt, and V. H. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant line: a second pathway of antigen presentation. Science 255:1264.
68. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489.
69. Hammond, S. A., R. P. Johnson, S. A. Kalams, B. D. Walker, M. Takiguchi, J. T. Safrit, R. A. Koup, and R. F. Siliciano. 1995. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. J. Immunol. 154:6140.
70. Anderson, K. S., J. Alexander, M. Wei, and P. Cresswell. 1993. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J. Immunol. 151:3407.
71. 2-microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol. 148:3723.